InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,475.09
(
0.27%
)
US TECH 100
19,258.40
(
0.49%
)
Dow Jones
39,169.52
(
0.13%
)
Brent Oil
86.53
(
1.67%
)
Bitcoin
62,878.06
(
0.44%
)
Post# of 252453
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 832
Posts 119964
Boards Moderated 17
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 95086

Sunday, 05/02/2010 5:10:16 PM

Sunday, May 02, 2010 5:10:16 PM

Post# of 252453
1Q10 sales of BMY’s top-selling drugs: 
 
             Sales (M$)  YoY Chg 
 Plavix        1700*      16% 
 Abilify        617*       5% 
 Reyataz        373       16% 
 Sustiva        335       15% 
 Avapro         314        4% 
 Baraclude      216       42% 
 Orencia        169       36% 
 Erbitux        166*       1% 
 Sprycel        131       49% 
 Ixempra         29       21% 
 Onglyza         10*      n/a 
  
 *Subject to co-marketing agreement; 
 BMY books a portion of worldwide sales.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up